Literature DB >> 11189823

Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif.

J Lorvick1, A H Kral, K Seal, L Gee, B R Edlin.   

Abstract

Mesh：

Year:  2001        PMID： 11189823      PMCID： PMC1446502          DOI： 10.2105/ajph.91.1.46

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  24 in total

1.  Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme.

Authors:  E Chamot; P de Saussure; B Hirschel; J J Déglon; L H Perrin
Journal:  AIDS       Date:  1992-04       Impact factor: 4.177

2.  High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.

Authors:  J I Esteban; J C López-Talavera; J Genescà; P Madoz; L Viladomiu; E Muñiz; C Martin-Vega; M Rosell; H Allende; X Vidal
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

3.  Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam.

Authors:  J A van den Hoek; H J van Haastrecht; J Goudsmit; F de Wolf; R A Coutinho
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

Review 4.  Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions.

Authors:  O S Levine; D Vlahov; K E Nelson
Journal:  Epidemiol Rev       Date:  1994       Impact factor: 6.222

5.  A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam.

Authors:  E J Van Ameijden; J A Van den Hoek; G H Mientjes; R A Coutinho
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

6.  Field effectiveness of needle disinfection among injecting drug users.

Authors:  D Vlahov; J Astemborski; L Solomon; K E Nelson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-07

7.  Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users.

Authors:  B Jose; S R Friedman; A Neaigus; R Curtis; J P Grund; M F Goldstein; T P Ward; D C Des Jarlais
Journal:  AIDS       Date:  1993-12       Impact factor: 4.177

Review 8.  The first and second decades of AIDS among injecting drug users.

Authors:  D C Des Jarlais
Journal:  Br J Addict       Date:  1992-03

9.  Bleach use and HIV seroconversion among New York City injection drug users.

Authors:  S Titus; M Marmor; D Des Jarlais; M Kim; H Wolfe; S Beatrice
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-07

10.  Hepatitis C virus infection among a cohort of Victorian injecting drug users.

Authors:  N Crofts; J L Hopper; D S Bowden; A M Breschkin; R Milner; S A Locarnini
Journal:  Med J Aust       Date:  1993-08-16       Impact factor: 7.738
View more
  49 in total

1.  Hepatitis C among drug users: déjà vu all over again?

Authors:  D C Des Jarlais; A Schuchat
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

Authors:  B R Edlin; K H Seal; J Lorvick; A H Kral; D H Ciccarone; L D Moore; B Lo
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

3.  Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.

Authors:  Andrew H Talal; Rositsa B Dimova; Randy Seewald; Raymond H Peterson; Marija Zeremski; David C Perlman; Don C Des Jarlais
Journal:  J Subst Abuse Treat       Date:  2012-03-08

4.  Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults.

Authors:  Judith I Tsui; Debbie M Cheng; Howard Libman; Carly Bridden; Jeffrey Samet
Journal:  AIDS Care       Date:  2012-01-24

5.  Injection drug users: the overlooked core of the hepatitis C epidemic.

Authors:  Brian R Edlin; Michael R Carden
Journal:  Clin Infect Dis       Date:  2006-01-20       Impact factor: 9.079

6.  Chronic pain and hepatitis C virus infection in opioid dependent injection drug users.

Authors:  Judith I Tsui; Debra S Herman; Malyna Kettavong; Bradley J Anderson; Michael D Stein
Journal:  J Addict Dis       Date:  2011-04

7.  Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis.

Authors:  Ricky N Bluthenthal; D Phuong Do; Brian Finch; Alexis Martinez; Brian R Edlin; Alex H Kral
Journal:  J Urban Health       Date:  2007-07-27       Impact factor: 3.671

8.  States and substance abuse treatment programs: funding and guidelines for infection-related services.

Authors:  Steven Kritz; Lawrence S Brown; R Jeffrey Goldsmith; Edmund J Bini; Jim Robinson; Donald Alderson; Patricia Novo; John Rotrosen
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

9.  Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs.

Authors:  Zdravko P Vassilev; Shiela M Strauss; Janetta Astone; Don C Des Jarlais
Journal:  J Behav Health Serv Res       Date:  2004 Apr-Jun       Impact factor: 1.505

10.  Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.

Authors:  Charlotte H S B van den Berg; Colette Smit; Margreet Bakker; Ronald B Geskus; Ben Berkhout; Suzanne Jurriaans; Roel A Coutinho; Katja C Wolthers; Maria Prins
Journal:  Eur J Epidemiol       Date:  2007-03-03       Impact factor: 8.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.